Today, an ever-growing number of devices are capable of measuring your heart. From rings to watches to smart toilet seats, heart-based metrics are more available to consumers than ever before. What began as something measured once or twice a year by a doctor with a stethoscope or EKG machine is now available 24/7 on our smart devices. What fueled this dramatic rise in home-based heart monitoring, and where will it go next? This post dives into some history behind our growing interest in monitoring our hearts from the comfort of home as well as what gaps remain between the kinds of signals doctors trust and what’s measured on your wrist. Over the past 75 years, what we track at home has steadily evolved from lifestyle choices to continuous physiological sensor data. Time has brought real progress, but the evolution remains incomplete, and heart health monitoring is ready for its next meaningful step forward. Consumer technology has made “heart data” mainstream, but the signals most tied to clinical decisions still primarily live inside the clinic. The next step forward is not more wellness scores; it’s collecting clinically meaningful signals in everyday life.
1950s–1960s: Risk Factors as a Harbinger of Future Health
In the 1950s, everyday heart health was defined by discrete negative events – an angina episode, a heart attack – rather than measurable progression over time. This changed with the Framingham study, which coined the term “risk factors” in 1961 after following three generations of participants and identifying characteristics that were linked to heart disease. This study and related work helped popularize the idea that things like elevated cholesterol and high blood pressure were predictors of future coronary disease. (PubMed)
What people started to “monitor”:
- Cholesterol (via periodic lab tests)
- Blood pressure
- Weight, smoking, activity (as personal habits rather than “metrics”)
What we gained: prevention thinking.
What we still lacked: any practical way to measure the heart without regular visits to the doctor.
1970s–1980s: Lifestyle Proxies Take Center Stage
Once risk factors entered public consciousness, people began to seek ways to gain some agency over their personal risk, often through lifestyle modifications. Two mega-trends defined the era:
1) Diet as destiny
Public policy and public health messaging increasingly emphasized reducing saturated fat and cholesterol to prevent heart disease. The 1977 “Dietary Goals for the United States” became a landmark in shaping the era’s “low-fat” zeitgeist (and sparked debate that continues today). (GovInfo)
2) The aerobic fitness boom
Popular culture embraced aerobic exercise as cardiovascular medicine. While figures like Ken Cooper helped ground the movement in exercise physiology (PMC), it quickly evolved into a lifestyle craze where heart health was symbolized by sweatbands and neon spandex, and aerobic effort itself became the goal.
What people monitored:
- Diet rules (low fat, low cholesterol, “heart-healthy” eating patterns)
- Exercise minutes (aerobics culture)
- Body weight
What we gained: better prevention framing + behavior change at scale
What we still lacked: a direct view of how the heart itself was doing
1980s–2000s: Vital Signs Go Portable
This is the period when heart health monitoring outside the clinic transitioned from health proxies to genuine physiological measurement, albeit with early technologies that made widespread adoption challenging.
Home blood pressure introduced
Guidelines increasingly emphasized hypertension detection and control, with out-of-office readings (home BP monitoring, ambulatory BP monitoring) valued as it became clear that clinic-based measurements often failed to reflect patients’ true day-to-day physiology – for example, many people experience a rise in blood pressure due to anxiety related to doctor’s visits (also known as “white-coat hypertension”). Still, these devices were mostly cuff-based and required patient education for proper measurements, limiting adoption mainly to individuals with existing conditions (AHA Journals).
Rhythm monitoring leaves the hospital
Ambulatory ECG monitoring (Holter monitoring) became a practical way to capture intermittent arrhythmias and correlate symptoms with rhythm. Although bulky and a bit uncomfortable to wear, these devices were an important way to capture rarely occurring cardiac signals that are nevertheless critical for making an accurate diagnosis (National Museum of American History)
What people monitored:
- Blood pressure at home
- Intermittent/short-term ECG outside the clinic (Holter/event monitoring)
What we gained: real-world vitals and rhythm
What we still lacked: scalable, comfortable ways to measure heart function beyond BP and rhythm
2000s–2010s: The Step Count Era
In the late 2000s and 2010s, consumer wearables turned health into something people checked daily. Fitness trackers popularized step counts, trends, and gamification, making “self-monitoring” mainstream (IEEE Spectrum – Fitbit). Step count, in particular, emerged as a dominant metric, anchored by the now familiar “10,000 steps” target. While step count itself is correlated with clinical outcomes, the origin of the 10,000-step goal traces not to cardiovascular science but to a mid-1960s Japanese pedometer called manpo-kei (“10,000-step meter”), whose name emphasized symbolism over physiology—including a character for “10,000” that loosely resembles a walking person. (www.heart.org)
What people monitored:
- Steps
- Sleep (often loosely defined)
- Resting heart rate trends
- Calories burned
What we gained: massive adoption and engagement
What we still lacked: despite being a meaningful advance over earlier lifestyle proxies, these metrics still measured what people did, not how the heart was functioning
2010s–2020s: Optical Sensors & Derived Cardiac Metrics
Wearables then upgraded from motion-only (steps) to physiology: photoplethysmography (PPG) made continuous pulse tracking easy, and consumer devices began offering HRV, stress scores, oxygen saturation, and more. (PMC)
But this is also where the limitations became clearer:
- PPG signals can be degraded by motion and other real-world factors
- Derived metrics (like stress scores) can be useful for trends but are often difficult to interpret clinically without context
At the same time, wearables started entering regulated territory. Apple’s irregular rhythm notification and ECG features received FDA De Novo clearances (FDA Access Data), and large studies evaluated smartwatch-based AF detection at population scale. Still, these measurements are mostly relegated to the realm of consumer wellness, occasionally prompting users to seek clinical evaluation rather than being clinical tools themselves.
What people monitored:
- Pulse rate
- HRV (“recovery,” “stress,” readiness)
- SpO₂
- Consumer ECG for spot checks (in some devices)
What we gained: continuous physiology and early detection pathways
What we still lacked: while pulse-based signals such as PPG provide meaningful physiological insight, their metrics do not consistently map into existing clinical workflows for assessing cardiac function
The Persistent Divide: Outside the Clinic vs Inside the Clinic
Inside the clinic, we measure signals used to make high-stakes decisions:
- rhythm (ECG)
- blood pressure and hemodynamics
- structure/function (echo imaging)
- mechanical performance and timing relationships (directly or indirectly)
Outside the clinic, most people measure:
- behaviors (steps, sleep duration)
- pulse-derived correlates (HR/HRV)
- intermittent rhythm screens (for some users)
That means we’ve democratized data, but not necessarily clinically actionable insight at the source. The next step forward is to close this gap by providing signals that reflect the heart’s mechanical performance and cardiopulmonary function in everyday life.
Why this matters now
Two things are newly true at the same time:
- Passive monitoring has become familiar: The adoption barrier for monitoring technologies has steadily fallen as people have grown accustomed to continuous, low-burden sensing in daily life. (PMC)
- The regulatory landscape is actively shifting: Recent policy changes signal increasing support of digital health, out-of-clinic care, and longitudinal monitoring across a range of chronic diseases and conditions. [see: FDA’s TEMPO pilot, CMS’s ACCESS Model]
As a result, the challenge has evolved from whether we can collect data outside the clinic to whether we can collect the right signals and translate them into measurements clinicians can use reliably in practice. Although it may seem like a small step, navigating the complex landscape of healthcare infrastructure and gaining the trust of doctors is a significant challenge. Monitoring devices of the future will need to meet high standards for accuracy and reliability to avoid false alarms or dismissal of true pathologies. Additionally, these systems will have to blend seamlessly into the clinical landscape as well as the lives of consumers – not an easy balance to strike. Fortunately, both technological and regulatory advances are converging to make this balancing act more manageable, meaning opportunities to bridge this gap are more prevalent than ever.
Leave a Reply